Also, fatty acid elongation has been implicated in metabolic disease, as exemplified by variation in fatty acid elongase 2 (Elovl2), which has been linked to reduced expression of the enzyme, diminished production of unsaturated fatty acids and a higher BMI (21). Here, ELOVL6 is linked to metabolic disease.